Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2

Siegel, 2015, Cancer statistics, 2015, CA Cancer J. Clin., 65, 5, 10.3322/caac.21254 Manfredi, 2006, Epidemiology and management of liver metastases from colorectal cancer, Ann. Surg., 244, 254, 10.1097/01.sla.0000217629.94941.cf Ciombor, 2015, Recent therapeutic advances in the treatment of colorectal cancer, Annu. Rev. Med., 66, 83, 10.1146/annurev-med-051513-102539 Kuipers, 2015, Colorectal cancer, Nat. Rev. Dis. Primers, 1, 15065, 10.1038/nrdp.2015.65 Kelland, 2007, The resurgence of platinum-based cancer chemotherapy, Nat. Rev. Cancer, 7, 573, 10.1038/nrc2167 Marin, 2012, Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer, Drug Metab. Rev., 44, 148, 10.3109/03602532.2011.638303 Meyerhardt, 2005, Systemic therapy for colorectal cancer, N. Engl. J. Med., 352, 476, 10.1056/NEJMra040958 Zhou, 2014, miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase, Mol. Oncol., 8, 83, 10.1016/j.molonc.2013.09.004 de Gramont, 2007, Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancer, J. Clin. Oncol., 25, 3224, 10.1200/JCO.2006.10.4380 Díaz Beveridge, 2012, Long-term results with oral fluoropyrimidines and oxaliplatin-based preoperative chemoradiotherapy in patients with resectable rectal cancer. A single-institution experience, Clin. Transl. Oncol., 14, 471, 10.1007/s12094-012-0826-y Temraz, 2014, Methods of overcoming treatment resistance in colorectal cancer, Crit. Rev. Oncol. Hematol., 89, 217, 10.1016/j.critrevonc.2013.08.015 Zhang, 2014, Inhibition of Girdin enhances chemosensitivity of colorectal cancer cells to oxaliplatin, World J. Gastroenterol., 20, 8229, 10.3748/wjg.v20.i25.8229 Chen, 2006, Pharmacokinetics and metabolism of the flavonoid scutellarin in humans after a single oral administration, Drug Metab. Dispos., 34, 1345, 10.1124/dmd.106.009779 Li, 2013, Scutellarin inhibits the growth and invasion of human tongue squamous carcinoma through the inhibition of matrix metalloproteinase-2 and -9 and αvβ6 integrin, Int. J. Oncol., 42, 1674, 10.3892/ijo.2013.1873 Hou, 2017, Scutellarin Inhibits Proliferation, Invasion, and Tumorigenicity in Human Breast Cancer Cells by Regulating HIPPO-YAP Signaling Pathway, Med. Sci. Monit., 23, 5130, 10.12659/MSM.904492 Mazurek, 2005, Pyruvate kinase type M2 and its role in tumor growth and spreading, Semin. Cancer Biol., 15, 300, 10.1016/j.semcancer.2005.04.009 Israelsen, 2013, PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells, Cell, 155, 397, 10.1016/j.cell.2013.09.025 Vander Heiden, 2009, Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science, 324, 1029, 10.1126/science.1160809 Li, 2018, PKM2, a potential target for regulating cancer, Gene, 668, 48, 10.1016/j.gene.2018.05.038 Tyers, 2019, Drug combinations: a strategy to extend the life of antibiotics in the 21st century, Nat. Rev. Microbiol., 17, 141, 10.1038/s41579-018-0141-x Lehár, 2009, Synergistic drug combinations tend to improve therapeutically relevant selectivity, Nat. Biotechnol., 27, 659, 10.1038/nbt.1549 de Gramont, 2000, Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer, J. Clin. Oncol., 18, 2938, 10.1200/JCO.2000.18.16.2938 Healey, 2013, Comparative effectiveness of 5-fluorouracil with and without oxaliplatin in the treatment of colorectal cancer in clinical practice, Anticancer Res., 33, 1053 Martinez-Outschoorn, 2011, Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells, Cell Cycle, 10, 2521, 10.4161/cc.10.15.16584 Cassidy, 2008, Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer, J. Clin. Oncol., 26, 2006, 10.1200/JCO.2007.14.9898 Zhang, 2019, PKM2, function and expression and regulation, Cell Biosci., 9, 52, 10.1186/s13578-019-0317-8 Jiang, 2014, PKM2 regulates chromosome segregation and mitosis progression of tumor cells, Mol. Cell, 53, 75, 10.1016/j.molcel.2013.11.001 Liu, 2015, PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma, Oncotarget, 6, 846, 10.18632/oncotarget.2749 Deschoemaeker, 2015, PHD1 regulates p53-mediated colorectal cancer chemoresistance, EMBO Mol. Med., 7, 1350, 10.15252/emmm.201505492 Schulze-Bergkamen, 2008, Bcl-x(L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells, World J. Gastroenterol., 14, 3829, 10.3748/wjg.14.3829 He, 2014, Overexpression of microRNA-122 re-sensitizes 5-FU-resistant colon cancer cells to 5-FU through the inhibition of PKM2 in vitro and in vivo, Cell Biochem. Biophys., 70, 1343, 10.1007/s12013-014-0062-x You, 2017, Scutellarin inhibits Hela cell growth and glycolysis by inhibiting the activity of pyruvate kinase M2, Bioorg. Med. Chem. Lett., 27, 5404, 10.1016/j.bmcl.2017.11.011 Kabanov, 2003, An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers, J. Control. Release, 91, 75, 10.1016/S0168-3659(03)00211-6 Zhou, 2012, Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells, Cancer Res., 72, 304, 10.1158/0008-5472.CAN-11-1674 Wen, 2013, Targeting cancer cell mitochondria as a therapeutic approach, Future Med. Chem., 5, 53, 10.4155/fmc.12.190 El-Mir, 2000, Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I, J. Biol. Chem., 275, 223, 10.1074/jbc.275.1.223 Liang, 2013, Ginsenoside Rb1 attenuates oxygen-glucose deprivation-induced apoptosis in SH-SY5Y cells via protection of mitochondria and inhibition of AIF and cytochrome c release, Molecules, 18, 12777, 10.3390/molecules181012777 Shoshan-Barmatz, 2010, Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo, Biochim. Biophys. Acta, 1797, 1281, 10.1016/j.bbabio.2010.03.003